Efficacy, immunogenicity and safety of respiratory syncytial virus prefusion F vaccine: systematic review and meta-analysis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Efficacy, immunogenicity and safety of respiratory syncytial virus prefusion F vaccine: systematic review and meta-analysis ; volume:24 ; number:1 ; day:6 ; month:5 ; year:2024 ; pages:1-13 ; date:12.2024
BMC public health ; 24, Heft 1 (6.5.2024), 1-13, 12.2024
- Urheber
-
Pang, Yi
Lu, Haishan
Cao, Demin
Zhu, Xiaoying
Long, Qinqin
Tian, Fengqin
Long, Xidai
Li, Yulei
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12889-024-18748-8
- URN
-
urn:nbn:de:101:1-2407152102117.370244249969
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pang, Yi
- Lu, Haishan
- Cao, Demin
- Zhu, Xiaoying
- Long, Qinqin
- Tian, Fengqin
- Long, Xidai
- Li, Yulei
- SpringerLink (Online service)
Ähnliche Objekte (12)
Protective efficacy and immunogenicity of a combinatory DNA vaccine against influenza A virus and the respiratory syncytial virus
Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults
Immunogenicity of an AS01-adjuvanted respiratory syncytial virus prefusion F (RSVPreF3) vaccine in animal models
Patient equity and respiratory syncytial virus Immunoprophylaxis
Immunogenicity of infectious pathogens and vaccine antigens
Mucosal bivalent live attenuated vaccine protects against human metapneumovirus and respiratory syncytial virus in mice
Respiratory Syncytial Virus Maternal Vaccination in Infants below 6 Months of Age: Meta-Analysis of Safety, Immunogenicity, and Efficacy
Severe Respiratory Syncytial Virus Infection
Challenges and opportunities for respiratory syncytial virus vaccines
A computational approach to design a polyvalent vaccine against human respiratory syncytial virus
Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model
Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Vaccine During Pregnancy for Prevention of Respiratory Syncytial Virus Among Infants in Argentina
Protective efficacy and immunogenicity of a combinatory DNA vaccine against influenza A virus and the respiratory syncytial virus
Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults
Immunogenicity of an AS01-adjuvanted respiratory syncytial virus prefusion F (RSVPreF3) vaccine in animal models
Patient equity and respiratory syncytial virus Immunoprophylaxis
Immunogenicity of infectious pathogens and vaccine antigens
Mucosal bivalent live attenuated vaccine protects against human metapneumovirus and respiratory syncytial virus in mice
Respiratory Syncytial Virus Maternal Vaccination in Infants below 6 Months of Age: Meta-Analysis of Safety, Immunogenicity, and Efficacy
Severe Respiratory Syncytial Virus Infection
Challenges and opportunities for respiratory syncytial virus vaccines
A computational approach to design a polyvalent vaccine against human respiratory syncytial virus
Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model
Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Vaccine During Pregnancy for Prevention of Respiratory Syncytial Virus Among Infants in Argentina
Protective efficacy and immunogenicity of a combinatory DNA vaccine against influenza A virus and the respiratory syncytial virus
Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults
Immunogenicity of an AS01-adjuvanted respiratory syncytial virus prefusion F (RSVPreF3) vaccine in animal models
Patient equity and respiratory syncytial virus Immunoprophylaxis
Immunogenicity of infectious pathogens and vaccine antigens
Mucosal bivalent live attenuated vaccine protects against human metapneumovirus and respiratory syncytial virus in mice
Respiratory Syncytial Virus Maternal Vaccination in Infants below 6 Months of Age: Meta-Analysis of Safety, Immunogenicity, and Efficacy
Severe Respiratory Syncytial Virus Infection
Challenges and opportunities for respiratory syncytial virus vaccines
A computational approach to design a polyvalent vaccine against human respiratory syncytial virus
Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model